Article
Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group.
World journal of gastroenterology - 7 Feb 2006
Furusyo Norihiro, Katoh Masaki, Tanabe Yuichi, Kajiwara Eiji, Maruyama Toshihiro, Shimono Junya, Sakai Hironori, Nakamuta Makoto, Nomura Hideyuki, Masumoto Akihide, Shimoda Shinji, Takahashi Kazuhiro, Azuma Koichi, Hayashi Jun
Abstract excerpt
AIM: To determine the efficacy of an interferon alpha and ribavirin combination treatment for Japanese patients infected with hepatitis C virus (HCV) of genotype 2, a multi-center study was retrospectively analyzed. METHODS: In total, 173 patients with HCV genotype 2 started to receive interferon-alpha subcutaneously thrice a week and 600-800 mg of ribavirin daily for 24 wk. RESULTS: The overall sustained...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.